Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : TGEN - Targeted Genetics Corporation -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (257)	2/20/2000 4:10:00 PM
From: biowa	Read Replies (1) \| Respond to of 557

Mike, but what matters is where Tgen is in five years, not so much now Which is why I've always slept at night, whether TGEN is at 1 and change or 28. Don't know if this current price holds (though I did add a little more near the bottom Friday, though actually just shifting between accounts after selling somewhat higher), but I hope that Parker and Johnson take this opportunity to raise capital. The only thing that has clouded my TGEN dreams has been the cash balance. biowa

To: Mike McFarland who wrote (257)	2/23/2000 2:08:00 AM
From: GlobalMarine	Respond to of 557

Don't forget their SUPER BLOCKBUSTER, Hemophilia A, factor VIII vector. In the CEO interview, Parker explicitly mentioned it, saying that there was appropriate expression, and even more than appropriate expression of over a year in mice. A better approach, chopping the factor VIII gene's superfluous parts so that it fits in an AAV vector, than AVGN's of chopping the gene in two and carrying each separately, though it's very nice to know that it too expresses.